afamelanotide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-09-07 and is reviewed periodically as new material appears.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanocytes are the pigment-producing cells of the skin, and they carry melanocortin-1 receptors on their surface. When the receptor is activated, cyclic adenosine monophosphate rises inside the cell and raises the activity of enzymes such as tyrosinase, which increases melanin output. Melanotan-2 binds melanocortin-1 receptors in vitro and in animal models, and this binding is generally described as the basis for the tanning effect. Other receptors account for different effects: melanocortin-4 receptors contribute to appetite and erectile signalling, while melanocortin-3 and melanocortin-5 receptors contribute to energy balance and exocrine function.
Early published reports described melanotan-2 as a tanning agent without sun protection, which means darkening is not the same as protection against ultraviolet radiation. Later studies explored the peptide in erectile dysfunction, hemorrhagic shock, and some skin conditions. No regulator in the United States or Europe has approved it for clinical use. Many products labelled melanotan-2 are sold without approval and their identity and purity are unverified. Its long-term safety in humans remains an open question.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic cyclic heptapeptide | Analog of alpha-MSH with an internal lactam bridge |
| Molecular weight | Approximately 1024 daltons | Free base value; salt forms differ |
| Appearance | White to off-white powder | Usually supplied as a lyophilized solid |
| Solubility | Freely soluble in water | Poorly soluble in nonpolar solvents |
| Typical storage | −20 °C, dry, protected from light | Repeated freeze-thaw cycles degrade peptides |
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
Melanocortin receptors comprise five subtypes with distinct tissue distributions and functions. Melanotan-2 is described in the literature as a non-selective agonist that engages several of these subtypes, including MC1R, MC3R, MC4R, and MC5R. MC1R is the subtype most directly linked to melanin production in skin cells. Because the compound is not subtype-selective, its observed effects in experimental settings are generally attributed to activity across multiple receptor pathways rather than to a single target.
Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.
Dr Christopher John Kent. Organist. For services to Music and Musicology. Azam Ahmed Khan. Executive Officer, Department for Work and Pensions and Founder, The Akhirah Team. For Charitable Services. William James David King. For services to Association Football in Northern Ireland. Gwendoline May Kingdon. For services to the community in South Molton, Devon. Elizabeth McDonald Kinnear. Volunteer, Guide Dogs Perth and District Branch. For services to Guide Dogs for the Blind in Perthshire. Juan Kotze. OCS Contracted Security Lead and Head of VIP Relations, Ministry of Justice. For Public Service. Kathleen Louisa Kynaston. Lately Chair, Shrewsbury Amateur Swimming Club. For services to Swimming and to the community in Shropshire. Rachael Isabel Lake. For services to the community in Walton on Thames, Surrey. Marino Teddy Michel Latour. Designated Safeguarding Professional, NHS South West London Integrated Care Board. For services to Safeguarding Adults. Amanda Jayne Lear. Enforcement Case Manager, Department for Work and Pensions. For services to the community in Moreton, Merseyside. Diana Rosemary Lee. For services to the community in Collingham, West Yorkshire. Frances Christina Lee. For services to the community in Acocks Green, West Midlands. Stephen Roger Lees JP. For services to the communities in Himley, Swindon and South Staffordshire. Morag Linda Lightning. Vice Chair, Turriff and District Community Council. For services to the community in Turriff, Aberdeenshire, particularly during Covid-19. Henry Lillystone. Fixtures Secretary, Leicestershire Foxes Sunday League.
== External links == Clinical Laboratory Improvement Amendments (CLIA), Centers for Medicare & Medicaid Services (CMS) CLIA Regulations Assessment Workgroup, CDC Clinical Laboratory Improvement Advisory Committee (CLIAC) CLIA Laboratory Lookup, CMS S&C's Quality, Certification and Oversight Reports (QCOR)
Importantly, the NPYS group can replace the Acm PG to yield an activated thiol. Using this method, Kiso and coworkers reported the first total synthesis of insulin in 1993. In this work, the A-chain of insulin was prepared with following protecting groups in place on its cysteines: CysA6(But), CysA7(Acm), and CysA11(But), leaving CysA20 unprotected.
== Function == Human eyes are somewhat distinctive in the animal kingdom in that the sclera is very plainly visible whenever the eye is open. This is not just due to the white color of the human sclera, which many other species share, but also to the fact that the human iris is relatively small and comprises a significantly smaller portion of the exposed eye surface compared to other animals. It is theorized that this adaptation evolved because of humans' social nature as the eye became a useful communication tool in addition to a sensory organ. It is believed that the exposed sclera of the human eye makes it easier for one individual to identify where another individual is looking, increasing the efficacy of this particular form of nonverbal communication, called cooperative eye hypothesis. Another hypothesis states that the distinctiveness of the human's sclera is due to genetic drift and sexual selection. A visibly white sclera is perceived as a sign of good health and youthfullness, this could have been a criterion of selection when looking for a mate. In this case, humans' ability to communicate with their eyes (glancing, cluing at others) would only be a consequence of a very visible sclera.
Sources: en.wikipedia.org
=== Chemistry === Pure lisinopril powder is white to off-white in color. Lisinopril is soluble in water (approximately 13 mg/L at room temperature), less soluble in methanol, and virtually insoluble in ethanol.
==== Depreciation tax deduction ==== For qualified production property of a taxpayer, the law makes permanent a 100% Section 179 depreciation deduction for the adjusted basis for the property acquired after January 19, 2025. Businesses are allowed to take a section 179 tax deduction for the cost of certain business property, software, leasehold improvements, and water utility property rather than deduct only the amount depreciated each year. Under the law, the maximum tax deduction is permanently increased from $1 million to $2.5 million and then phased out to $4 million, all of which will be indexed for inflation in future years. These changes are effective for tax years beginning after December 31, 2024. The law also created a new depreciation allowance for nonresidential real property that is used as an essential part of an activity that includes the manufacturing, production, or refining of certain tangible products that significantly transforms the product. Types of property that do not qualify include nonresidential real property used for offices, administrative services, lodging, parking, sales activities, software development, and software engineering. The property's construction must begin between January 20, 2025, and December 31, 2028, and it must be placed in service in the U.S. or U.S. possessions on or before December 31, 2030.
The lift force is not generated by the air taking the same time to travel above and below an aircraft's wing. This misconception, sometimes called the equal transit-time fallacy, is widespread among textbooks and non-technical reference books, and even appears in pilot training materials. In fact, the air moving over the top of an aerofoil generating lift is always moving much faster than the equal transit theory would imply, as described in the incorrect and correct explanations of lift force.
Many international Hardee's franchises are located in countries in the Middle East and Pakistan, most being owned and operated by Americana Group. The Americana Group opened the Middle East's first Hardee's restaurant in Kuwait in June 1980. As of 2016, there are over 300 Hardee's restaurants throughout Asia and the Middle East, specifically in Bahrain, Egypt, Iraq, Jordan, Kazakhstan, Kuwait, Lebanon, Oman, Palestine, Pakistan, Qatar, Saudi Arabia, United Arab Emirates, and plans to open in Israel. Singapore had a Hardee's franchise first opened in 1984, but the last three outlets closed in 1988. Hardee's opened a store in South Korea in 1990, but it pulled in 2004, due to poor performance. Hardee's also used to operate in Hong Kong, but it pulled out in 2006, due to licensing issues with its US parent. Specifically, in the Middle East, the Hardee's menu does not include any pork items and each beef is certified Halal due to religious and cultural beliefs. The same menu is offered at Hardee's locations in Pakistan, which opened its first location in the country in 2009 in Lahore. Hardee's currently has 18 locations in Pakistan, with six in Lahore, four in Karachi, two each in Islamabad and Rawalpindi and one each in Faisalabad, Bhera, Peshawar and Multan. In 2014, it opened a restaurant in Erbil, Iraqi Kurdistan. There is also a Hardee's location at Jomo Kenyatta International Airport in Nairobi.
== Venom == The venom of the Wagler's pit viper contains four novel peptides (Waglerins 1-4). The Waglerins produce fatal respiratory paralysis of adult mice. An initial study indicated that micromolar concentrations of Waglerin 1 act both pre- and postsynaptically to inhibit transmission across rat neuromuscular junctions. However, Waglerin-1 is a more potent inhibitor of transmission across the mouse neuromuscular junction. A subsequent study demonstrated that Waglerin-1 inhibited the adult mouse endplate response to acetylcholine with an IC50 of 50 nanomolar. In striking contrast, transmission across neuromuscular junctions of neonatal or transgenic mice lacking the adult acetylcholine receptor was not altered by micromolar concentrations of Waglerin-1. Biochemical studies demonstrated that the exquisite selectivity of Waglerin-1 for the adult mouse acetylcholine receptor relies upon several amino acid residues unique to the epsilon subunit of the adult mouse acetylcholine receptor. Waglerin-1's selectivity for the epsilon-subunit containing acetylcholine receptor of adult mice is complemented by selectivity of small peptide toxins purified from the venom of Conus geographus and Conus pergrandis for the gamma-subunit containing acetylcholine receptor of neonatal skeletal muscle. The Waglerins and complementary conotoxins are useful tools to discover the contribution of acetylcholine receptor subunits to synaptogenesis. In addition, study of the Waglerins and related toxic peptides may lead to the discovery of novel molecular targets for drug development.
Sources: en.wikipedia.org
== Pre-atomic chemistry == Working in the late 17th century, Robert Boyle developed the concept of a chemical element as substance different from a compound. Near the end of the 18th century, a number of important developments in chemistry emerged without referring to the notion of an atomic theory. The first was Antoine Lavoisier who showed that compounds consist of elements in constant proportion, redefining an element as a substance which scientists could not decompose into simpler substances by experimentation. This brought an end to the ancient idea of the elements of matter being fire, earth, air, and water, which had no experimental support. Lavoisier showed that water can be decomposed into hydrogen and oxygen, which in turn he could not decompose into anything simpler, thereby proving these are elements. Lavoisier also defined the law of conservation of mass, which states that in a chemical reaction, matter does not appear nor disappear into thin air; the total mass remains the same even if the substances involved were transformed. In 1797 the French chemist Joseph Proust established the law of definite proportions, which states that if a compound is broken down into its constituent chemical elements, then the masses of those constituents will always have the same proportions by weight, regardless of the quantity or source of the original compound. This definition distinguished compounds from mixtures.
=== Lebanon === Hitchens described Lebanon as "the most plural society in the region" and criticized the Syrian regime for continuing to manipulate the country by proxies and by surrogates notably Hezbollah and the SSNP. In an article written on Slate, Hitchens stated:
=== Other musculoskeletal === A 2014 Cochrane review of musculoskeletal injuries found very weak evidence for a decrease in pain in the short term, and no difference in function in the short, medium or long term. It has not been shown to be useful for bone healing. A 2016 review of bone graft augmentation found only one study reporting a difference in bone augmentation, while four studies found no difference. As compared to other conservative treatments for non-surgical orthopedic illnesses (e.g. steroid injection for plantar fasciitis), evidence does not support the use of PRP as a conservative treatment. A 2018 review found that evidence was lacking for Achilles tendinopathy. A 2019 meta-analysis found that, for most outcomes in Achilles tendinopathy, PRP treatment did not differ from placebo treatment. A 2019 study conducted an umbrella review that "considered studies that included populations with differing levels of physical activity, including studies on the sporting population (professional and/or recreational athletes) and studies didn't explicitly mention involving a sporting population." This inquiry reported only poor quality evidence that PRP offers any clinical benefits for treatment in acute muscle, tendon, and ligament injuries in any population.
=== International Food Safety Authorities Network (INFOSAN) === The International Food Safety Authorities Network (INFOSAN) is a joint program of the WHO and FAO. INFOSAN has been connecting national authorities from around the globe since 2004, with the goal of preventing the international spread of contaminated food and foodborne disease and strengthening food safety systems globally. This is done by:
On January 8, 2026, the House of Representatives voted 397 - 28 for a three-bill package, known as a "minibus", which House and Senate negotiators had put forward earlier that week. There was a partial shutdown from January 31 till February 3, 2026. On February 3, the House passed and President Trump signed the Senate version to fund the United States government through September, which the exception of the Department of Homeland Security (DHS) only being funded through February 13. This is the result of disagreement between Democrats and Republicans over how to move forward from the situation in Minneapolis, Minnesota. In the end, 21 House Democrats had voted for the funding bill and 21 House Republicans had voted against it.
Sources: en.wikipedia.org
It is a synthetic seven-amino-acid peptide modeled on alpha-melanocyte-stimulating hormone. It carries two non-natural substitutions and a cyclic bridge that increase its stability relative to the natural hormone. It circulates as a research chemical and is not an approved medicine.
Melanotan-1, also called afamelanotide, is a shorter linear analog with a different amino acid sequence and no lactam ring. It has been evaluated in formal clinical programs, while melanotan-2 has not. The two are distinct molecules and are not interchangeable.
No. Bremelanotide is a related but distinct cyclic peptide that reached approved status for one specific clinical indication. Melanotan-2 is a separate molecule with its own sequence and properties. Shared ancestry in the melanocortin family does not make them the same substance.
No. It is a laboratory-made peptide, while the natural hormone is alpha-melanocyte-stimulating hormone, a longer peptide produced by the pituitary gland and by skin cells. Melanotan-2 mimics only a short active region of that hormone and contains non-natural residues such as D-phenylalanine.